Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons
Labchan Rajbhandari, Priya Shukla, Balaji Jagdish, Abby Mandalla, Qingxue Li, Mir A. Ali, Ho-Jae Lee, Gabsang Lee, Tomohiko Sadaoka, Jeffrey I. Cohen, Arun Venkatesan
Abstract
Varicella-zoster virus (VZV) causes chickenpox, gains access to neurons during primary infection where it resides lifelong, and can later be reactivated. Reactivation is associated with shingles and postherpetic neuralgia, as well as with severe neurologic complications, including vasculitis and encephalitis. Although the varicella vaccine substantially decreases morbidity and mortality associated with primary infection, the vaccine cannot prevent the development of neuronal latency, and vaccinated populations are still at risk for reactivation. Furthermore, immunocompromised individuals are at higher risk for VZV reactivation and associated complications. Little is known regarding how VZV enters neurons. Here, we identify nectin-1 as an entry mediator of VZV in human neurons. Identification of nectin-1 as a neuronal VZV entry mediator could lead to improved treatments and preventative measures to reduce VZV related morbidity and mortality.